...
机译:坏死抑素:潜在的新型心脏保护剂?
The Hatter Cardiovascular Institute University College London Hospital and Medical School 67 Chenies Mews London WC1E 6HX UK;
The Hatter Cardiovascular Institute University College London Hospital and Medical School 67 Chenies Mews London WC1E 6HX UK;
The Hatter Cardiovascular Institute University College London Hospital and Medical School 67 Chenies Mews London WC1E 6HX UK;
The Hatter Cardiovascular Institute University College London Hospital and Medical School 67 Chenies Mews London WC1E 6HX UK;
The Hatter Cardiovascular Institute University College London Hospital and Medical School 67 Chenies Mews London WC1E 6HX UK;
The Hatter Cardiovascular Institute University College London Hospital and Medical School 67 Chenies Mews London WC1E 6HX UK;
necrostatin; cardioprotection; infarct size; mitochondrial permeability transition pore;
机译:坏死抑制素的心脏保护作用需要线粒体通透性转变孔的亲环素-D成分
机译:Wortmannin,一种有效的抗中性粒细胞药物,在心肌缺血/再灌注中具有心脏保护作用
机译:坏死抑制素-1减轻镉诱导的坏死细胞死亡:潜在的坏死抑制素1作用位点。
机译:缺氧诱导因子1α作为心脏保护剂
机译:释放氮氧化物的前药,作为抗炎,抗癌和心脏保护剂
机译:坏死抑制素的心脏保护作用需要线粒体通透性过渡孔的亲环素D成分
机译:Necrostatin的心脏保护作用需要线粒体渗透性过渡孔的细胞素-D组分